Market Tracker

10/20 5:16pm ET

Neogenomics Inc (NASDAQ:NEO)

8.84
Delayed Data
As of Oct 20
 +0.03 / +0.34%
Today’s Change
6.90
Today|||52-Week Range
11.63
+3.15%
Year-to-Date
Company News For Oct 16, 2017
Oct 16 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close8.81
Today’s open8.88
Day’s range8.73 - 8.96
Volume271,906
Average volume (3 months)352,328
Market cap$701.8M
Dividend yield--
Data as of 3:59pm ET, 10/20/2017

Growth & Valuation

Earnings growth (last year)-875.00%
Earnings growth (this year)-3.33%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+144.57%
P/E ratioNM
Price/Sales2.72
Price/Book4.24

Competitors

 Today’s
change
Today’s
% change
NTRANatera Inc+0.18+1.38%
ENZEnzo Biochem Inc0.000.00%
KANGiKang Healthcare Gro...+0.06+0.45%
RDNTRadNet Inc+0.20+1.83%
Data as of 4:02pm ET, 10/20/2017

Financials

Next reporting dateOctober 25, 2017
EPS forecast (this quarter)$0.03
Annual revenue (last year)$244.1M
Annual profit (last year)-$5.7M
Net profit margin-2.34%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Chief Scientific Officer &
VP-Operations
Steven G. Brodie
Corporate headquarters
Fort Myers, Florida

Forecasts